Asian Phytoceuticals Past Earnings Performance

Past criteria checks 5/6

Asian Phytoceuticals has been growing earnings at an average annual rate of 7.3%, while the Personal Products industry saw earnings growing at 10.8% annually. Revenues have been declining at an average rate of 3.2% per year. Asian Phytoceuticals's return on equity is 17.8%, and it has net margins of 36.7%.

Key information

7.3%

Earnings growth rate

6.8%

EPS growth rate

Personal Products Industry Growth	3.7%
Revenue growth rate	-3.2%
Return on equity	17.8%
Net Margin	36.7%
Last Earnings Update	31 Dec 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Asian Phytoceuticals makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

SET:APCO Revenue, expenses and earnings (THB Millions)
Date	Revenue	Earnings	G+A Expenses
31 Dec 23	293	107	120
30 Sep 23	303	116	120
30 Jun 23	289	106	119
31 Mar 23	278	98	119
31 Dec 22	250	81	116
30 Sep 22	238	75	112
30 Jun 22	230	73	108
31 Mar 22	231	75	106
31 Dec 21	223	69	106
30 Sep 21	228	64	117
30 Jun 21	235	62	125
31 Mar 21	234	62	125
31 Dec 20	248	70	125
30 Sep 20	239	69	115
30 Jun 20	233	67	110
31 Mar 20	233	60	113
01 Jan 20	248	58	131
30 Sep 19	291	68	157
30 Jun 19	327	78	177
31 Mar 19	351	85	192
31 Dec 18	370	95	195
30 Sep 18	378	100	201
30 Jun 18	395	107	208
31 Mar 18	417	109	223
31 Dec 17	416	108	225
30 Sep 17	412	121	229
30 Jun 17	413	123	231
31 Mar 17	416	131	226
31 Dec 16	421	131	230
30 Sep 16	443	124	231
30 Jun 16	425	112	229
31 Mar 16	412	103	227
31 Dec 15	409	101	225
30 Sep 15	380	81	223
30 Jun 15	398	94	220
31 Mar 15	422	112	218
31 Dec 14	426	119	215
30 Sep 14	435	127	209
30 Jun 14	413	114	208
31 Mar 14	385	96	201
31 Dec 13	349	79	193
30 Sep 13	330	71	191
30 Jun 13	315	64	186

Quality Earnings: APCO has high quality earnings.

Growing Profit Margin: APCO's current net profit margins (36.7%) are higher than last year (32.3%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: APCO's earnings have grown by 7.3% per year over the past 5 years.

Accelerating Growth: APCO's earnings growth over the past year (32.8%) exceeds its 5-year average (7.3% per year).

Earnings vs Industry: APCO earnings growth over the past year (32.8%) exceeded the Personal Products industry 32.8%.

Asian Phytoceuticals Past Earnings Performance

Past criteria checks 5/6

Key information

Recent past performance updates

Full year 2023 earnings released: EPS: ฿0.18 (vs ฿0.14 in FY 2022)

Second quarter 2023 earnings released: EPS: ฿0.042 (vs ฿0.029 in 2Q 2022)

First quarter 2023 earnings released: EPS: ฿0.054 (vs ฿0.026 in 1Q 2022)

Third quarter 2022 earnings released: EPS: ฿0.035 (vs ฿0.032 in 3Q 2021)

Second quarter 2022 earnings released: EPS: ฿0.029 (vs ฿0.03 in 2Q 2021)

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Recent updates

Upcoming dividend of ฿0.18 per share

Full year 2023 earnings released: EPS: ฿0.18 (vs ฿0.14 in FY 2022)

Asian Phytoceuticals Public Company Limited, Annual General Meeting, Apr 22, 2024

New minor risk - Market cap size

Second quarter 2023 earnings released: EPS: ฿0.042 (vs ฿0.029 in 2Q 2022)

Investor sentiment improves as stock rises 15%

New minor risk - Share price stability

Investor sentiment improves as stock rises 15%

First quarter 2023 earnings released: EPS: ฿0.054 (vs ฿0.026 in 1Q 2022)

Upcoming dividend of ฿0.15 per share at 3.0% yield

Investor sentiment deteriorates as stock falls 33%

Investor sentiment deteriorated over the past week

Insufficient new directors

Third quarter 2022 earnings released: EPS: ฿0.035 (vs ฿0.032 in 3Q 2021)

Investor sentiment deteriorated over the past week

Second quarter 2022 earnings released: EPS: ฿0.029 (vs ฿0.03 in 2Q 2021)

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Investor sentiment improved over the past week

Insufficient new directors

Asian Phytoceuticals Public Company Limited Approves Dividend, Payable on May 9, 2022

Upcoming dividend of ฿0.12 per share

Investor sentiment improved over the past week

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Asian Phytoceuticals Public Company Limited, Annual General Meeting, Apr 18, 2022

Asian Phytoceuticals Public Company Limited Proposes Dividend for 2021, Payable on May 9, 2022

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS ฿0.032 (vs ฿0.027 in 3Q 2020)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Second quarter 2021 earnings released: EPS ฿0.03 (vs ฿0.03 in 2Q 2020)

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS ฿0.02 (vs ฿0.03 in 1Q 2020)

Asian Phytoceuticals Public Company Limited Announces the Progress of Apco's Research and Development

Upcoming dividend of ฿0.12 per share

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

New 90-day low: ฿3.60

Asian Phytoceuticals Public Company Limited, Annual General Meeting, Apr 19, 2021

Full year 2020 earnings released: EPS ฿0.12 (vs ฿0.10 in FY 2019)

New 90-day low: ฿3.60

New 90-day low: ฿3.60

Market pulls back on stock over the past week

New 90-day low: ฿2.66

Third quarter 2020 earnings released: EPS ฿0.03

New 90-day low - ฿3.58

New 90-day low - ฿3.60

First half earnings released

New 90-day high - ฿4.22

Revenue & Expenses BreakdownBeta

Earnings and Revenue History

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Return on Equity

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Revenue & Expenses Breakdown
Beta